Guru Ownership Trend
Guru Analysis for Lexeo Therapeutics, Inc. (LXEO)
Lexeo Therapeutics, Inc. (LXEO), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $10.38 M.
Top institutional holders include Steven Cohen and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $3.38 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 0.7%. Conversely, Steven Cohen reduced exposure by 11.3%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Lexeo Therapeutics, Inc. (LXEO)
Major holders include Steven Cohen ($9.65 M), Cliff Asness ($1.95 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 2.02 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $3.38 M, with 1 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited LXEO. The total reported sell value was $3.39 M.
Yes, 0 managers opened new positions in LXEO, and 1 increased their existing holdings. The total reported buy value was $12,840.38.